Trials / Completed
CompletedNCT03413124
Bioavailability Study of MGL-3196 Tablets Compared to Capsules
A Single Center, Open-Label, Single-Dose, Cross-over, Bioavailability Study of MGL-3196 Tablets Compared to Capsules in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Madrigal Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics of MGL-3196 capsules with MGL-3196 tablets in healthy male subjects and female subjects not of child-bearing potential.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MGL-3196 Tablet | MGL-3196 in Tablet form |
| DRUG | MGL-3196 Capsule | MGL-3196 in Capsule form |
Timeline
- Start date
- 2018-02-05
- Primary completion
- 2018-02-17
- Completion
- 2018-03-13
- First posted
- 2018-01-29
- Last updated
- 2019-09-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03413124. Inclusion in this directory is not an endorsement.